Add time:07/13/2019         Source:sciencedirect.com

Multiple intracellular transforming signals regulate eukaryotic translation initiation factor 4E (eIF4E)-binding protein (4E-BP1). The signals result in hierarchical phosphorylation of 4E-BP1, resulting in release of eIF4E, relieving translational repression and enhancing oncogenic protein synthesis. This study assessed the expression of phosphorylated 4E-BP1 (p-4E-BP1) in gastric cancer and its correlation with clinicopathological parameters and patient survival. Tissue microarray blocks were generated from 179 gastric carcinomas and immunohistochemically stained for p-4E-BP1. The expression of p-4E-BP1 was higher in tumors that were intestinal-type (P = 0.028); had a diameter smaller than 5 cm (P = 0.001); were lower pathological T stage (P < 0.001), N stage (P = 0.004), or TNM stage (P < 0.001); did not have distant metastasis (P = 0.027). High p-4E-BP1 expression significantly correlated with prolonged overall survival (P = 0.046) and disease-free survival (P = 0.035), but was not an independent prognostic factor in multivariate analysis. Our results indicate that p-4E-BP1 is more highly expressed in early gastric cancers than in advanced ones, and has limited potential as an independent prognostic biomarker in patients with gastric cancer. Larger well-controlled studies with molecular validation are warranted to elucidate more exact prognostic significance and working mechanism of p-4E-BP1 in gastric cancer.

We also recommend Trading Suppliers and Manufacturers of 1-[(4E)-6-bromo-4-hydroxyimino-2,3-dihydroquinolin-1-yl]-2-methyl-prop an-1-one (cas 81892-48-0). Pls Click Website Link as below: cas 81892-48-0 suppliers